Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2022

  • ID: 4461024
  • Report
  • Region: Global
  • 247 Pages
  • Markets and Markets
1 of 4
Oligonucleotide Synthesis Market worth 2.46 Billion USD by 2022

FEATURED COMPANIES

  • Agilent Technologies
  • ATDBio
  • Bioautomation
  • Bio-Synthesis
  • Eurofins Genomics
  • Eurogentec
  • MORE

“The global oligonucleotide synthesis market projected to grow at a CAGR of 10.9%.”

The global oligonucleotide synthesis market is expected to reach USD 2.46 billion by 2022 from USD 1.47 billion in 2017 at a CAGR of 10.9%. This market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.
Growth in this market is mainly driven the increasing R&D expenditure by pharmaceutical and biotechnology companies, rising demand for synthesized oligonucleotides from the growing field of molecular diagnostics, rising venture capital investments, and increasing demand for synthetic genes. However, the price erosion of synthesized oligos and lack of regulations for therapeutic oligos are some factors that may hinder the growth of this market.

“Synthesized oligonucleotides are expected to grow at the highest CAGR during the forecast period.”

Based on product, the market is segmented into synthesized oligonucleotides, reagents, and equipment. The synthesized oligonucleotides segment is expected to grow at the highest CAGR during the forecast period The increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics is a key market driver in this segment. The rising availability and demand for custom oligos also contribute to the growth of the synthesized oligonucleotides market.

“The research segment is expected to hold the largest share of the market in 2017.”

Based on application, the market is segmented into research, diagnostics, and therapeutics. The research segment is estimated to hold the largest share of the oligonucleotide synthesis market in 2017. The market growth for research applications is mainly driven by the developments in the fields of gene synthesis and NGS. Oligos are widely used in technologies such as PCR, qPCR, gene synthesis, isothermal nucleic acid amplification technology (INAAT), microarray, hybridization, DNA sequencing, and next-generation sequencing (NGS).

“Academic research institutes are expected to dominate the market during the forecast period.”

Based on end user, the market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. The academic research institutes segment is expected to dominate the market during the forecast period. With the increasing funding pouring into institutes to conduct research, the demand for oligonucleotides is bound to increase. To meet this need, companies are launching products and entering into agreements with different research institutes to supply oligonucleotides for research purposes. For instance, in August 2015, Eurofins Genomics launched NGS tests for the identification of non-targeted microorganisms, including 16S Microbiome Profiling for academia and research.

“APAC to witness the highest growth during the forecast period.”

In 2017, North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period. This can be attributed to factors such as the growing availability of synthesized oligos, along with an increase in R&D funding and activities in the APAC region. The increasing focus of prominent players on APAC is also supporting market growth in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 36%; Tier 2 - 46%; Tier 3 - 18%.
  • By Designation: C-level- 26%; D-level- 45%; Others- 29%.
  • By Region: North America-41%; Europe-31%; Asia Pacific-20%; Latin America- 5%, Middle East and Africa-3%

List of companies profiled in the report

  • Agilent Technologies (US)
  • ATDBio (UK)
  • Bio-Synthesis (US)
  • BioAutomation (US)
  • LGC Biosearch Technologies (US)
  • Eurofins Genomics (Germany)
  • Eurogentec (Belgium)
  • GeneDesign (Japan)
  • GE Healthcare (US)
  • GenScript (US)
  • Integrated DNA Technologies (IDT) (US)
  • Nitto Denko Avecia (US)
  • Thermo Fisher Scientific (US)
  • TriLink Biotechnologies (US)
  • Sigma-Aldrich Corporation (Sigma-Aldrich) (US) (part of Merck KGAA (Germany)

Research Coverage:

The report provides an overview of the oligonucleotide synthesis market. It aims at estimating the market size and future growth potential of this market across different segments such as product, application, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall oligonucleotide synthesis market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Agilent Technologies
  • ATDBio
  • Bioautomation
  • Bio-Synthesis
  • Eurofins Genomics
  • Eurogentec
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.2 Secondary Data
2.2.1 Secondary Sources
2.3 Primary Data
2.3.1 Key Data From Primary Sources
2.3.2 Key Industry Insights
2.4 Market Size Estimation
2.4.1 Market Size Estimation: Bottom-Up Approach
2.4.2 Market Size Estimation: Top-Down Approach
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Attractive Opportunities in Oligonucleotide Synthesis Market
4.2 Oligonucleotides Synthesis Market, By Synthesized Oligonucleotides Products
4.3 Market, By Synthesized Oligonucleotides Type
4.4 Europe: Market, By Research Application and Country
4.5 Oligonucleotide Synthesis Market, By Therapeutic Application
4.6 Market, By End User
4.7 Geographic Snapshot: Market

5 Market Overview
5.1 Introduction
5.2 Market Drivers
5.2.1 Increasing Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications
5.2.2 Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies
5.2.3 Rise in Venture Capital Investments
5.3 Market Restraints
5.3.1 Price Erosion of Synthesized Oligonucleotides
5.3.2 Lack of A Unified Set of Regulations for Therapeutic Oligonucleotides
5.4 Market Opportunities
5.4.1 Emerging Asian Markets
5.5 Market Challenges
5.5.1 Large-Scale Synthesis of Oligonucleotides
5.5.2 Delivery of Oligonucleotide Drugs to Specific Targets
5.6 Industry Trends

6 Oligonucleotide Synthesis Market, By Product
6.1 Introduction
6.2 Synthesized Oligonucleotides
6.2.1 By Product
6.2.1.1 Primers
6.2.1.2 Probes
6.2.1.3 Large-Scale Synthesis Oligonucleotides
6.2.1.4 Intermediate-Scale Synthesis Oligonucleotides
6.2.1.5 Linkers & Adaptors
6.2.2 By Type
6.2.2.1 Custom Oligonucleotides
6.2.2.2 Pre-Designed Oligonucleotides
6.3 Reagents
6.4 Equipment

7 Oligonucleotide Synthesis Market, By Application
7.1 Introduction
7.2 Research
7.2.1 PCR
7.2.2 QPCR
7.2.3 Sequencing
7.2.4 Gene Synthesis
7.2.5 Other Research Applications
7.3 Diagnostics
7.4 Therapeutics
7.4.1 RNAi
7.4.2 Nucleic Acid Aptamers
7.4.3 DNA/Antisense Oligonucleotides
7.4.4 Immunotherapy Applications

8 Oligonucleotide Synthesis Market, By End User
8.1 Introduction
8.2 Academic Research Institutes
8.3 Pharmaceutical and Biotechnology Companies
8.4 Diagnostic Laboratories
8.5 Other End Users

9 Oligonucleotide Synthesis Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Rest of Europe (RoE)
9.4 Asia Pacific (APAC)
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific (RoAPAC)
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Partnerships, Agreements, Contracts, and Collaborations
10.3.2 Product Launches, Upgrades, and Approvals
10.3.3 Expansions
10.3.4 Acquisitions

11 Company Profiles
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 Integrated DNA Technologies
11.2 Merck KGaA
11.3 Eurofins Genomics
11.4 Thermo Fisher Scientific
11.5 Bioautomation
11.6 Agilent Technologies
11.7 Eurogentec
11.8 GE Healthcare
11.9 LGC Biosearch Technologies
11.10 Nitto Denko Avecia
11.11 Genscript
11.12 Genedesign (Part of Ajinomoto)
11.13 TriLink Biotechnologies (Part of Maravai Lifesciences)
11.14 Bio-Synthesis
11.15 ATDBio

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details

List of Tables:
Table 1 Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Region, 2015-2022 (USD Million)
Table 2 North America: Market for Synthesized Oligonucleotides, By Country, 2015-2022 (USD Million)
Table 3 Europe: Market for Synthesized Oligonucleotides, By Country, 2015-2022 (USD Million)
Table 4 Asia Pacific: Market for Synthesized Oligonucleotides, By Country, 2015-2022 (USD Million)
Table 5 Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Product Type, 2015-2022 (USD Million)
Table 6 Market for Primers, By Region, 2015-2022 (USD Million)
Table 7 North America: Market for Primers, By Country, 2015-2022 (USD Million)
Table 8 Europe: Market for Primers, By Country, 2015-2022 (USD Million)
Table 9 Asia Pacific: Oligonucleotide Synthesis Market for Primers, By Country, 2015-2022 (USD Million)
Table 10 Market for Probes, By Region, 2015-2022 (USD Million)
Table 11 North America: Market for Probes, By Country, 2015-2022 (USD Million)
Table 12 Europe: Oligonucleotide Synthesis Market for Probes, By Country, 2015-2022 (USD Million)
Table 13 Asia Pacific: Market for Probes, By Country, 2015-2022 (USD Million)
Table 14 Market for Large-Scale Synthesis Oligonucleotides, By Region, 2015-2022 (USD Million)
Table 15 North America: Oligonucleotide Synthesis Market for Large-Scale Synthesis Oligonucleotides, By Country, 2015-2022 (USD Million)
Table 16 Europe: Market for Large-Scale Synthesis Oligonucleotides, By Country, 2015-2022 (USD Million)
Table 17 Asia Pacific: Market for Large-Scale Synthesis Oligonucleotides, By Country, 2015-2022 (USD Million)
Table 18 Market for Intermediate-Scale Synthesis Oligonucleotides, By Region, 2015-2022 (USD Million)
Table 19 North America: Market for Intermediate-Scale Synthesis Oligonucleotides, By Country, 2015-2022 (USD Million)
Table 20 Europe: Oligonucleotide Synthesis Market for Intermediate-Scale Synthesis Oligonucleotides, By Country, 2015-2022 (USD Million)
Table 21 Asia Pacific: Market for Intermediate-Scale Synthesis Oligonucleotides, By Country, 2015-2022 (USD Million)
Table 22 Oligonucleotide Synthesis Market for Linkers & Adaptors, By Region, 2015-2022 (USD Million)
Table 23 North America: Market for Linkers & Adaptors, By Country, 2015-2022 (USD Million)
Table 24 Europe: Market for Linkers & Adaptors, By Country, 2015-2022 (USD Million)
Table 25 Asia Pacific: Market for Linkers & Adaptors, By Country, 2015-2022 (USD Million)
Table 26 Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015-2022 (USD Million)
Table 27 Market for Custom Oligonucleotides, By Region, 2015-2022 (USD Million)
Table 28 North America: Market for Custom Oligonucleotides, By Country, 2015-2022 (USD Million)
Table 29 Europe: Oligonucleotide Synthesis Market for Custom Oligonucleotides, By Country, 2015-2022 (USD Million)
Table 30 Asia Pacific: Market for Custom Oligonucleotides, By Country, 2015-2022 (USD Million)
Table 31 Market for Pre-Designed Oligonucleotides, By Region, 2015-2022 (USD Million)
Table 32 North America: Market for Pre-Designed Oligonucleotides, By Country, 2015-2022 (USD Million)
Table 33 Europe: Oligonucleotide Synthesis Market for Pre-Designed Oligonucleotides, By Country, 2015-2022 (USD Million)
Table 34 Asia Pacific: Market for Pre-Designed Oligonucleotides, By Country, 2015-2022 (USD Million)
Table 35 Oligonucleotide Synthesis Market for Reagents, By Region, 2015-2022 (USD Million)
Table 36 North America: Market for Reagents, By Country, 2015-2022 (USD Million)
Table 37 Europe: Market for Reagents, By Country, 2015-2022 (USD Million)
Table 38 Asia Pacific: Market for Reagents, By Country, 2015-2022 (USD Million)
Table 39 Market for Equipment, By Region, 2015-2022 (USD Million)
Table 40 North America: Market for Equipment, By Country, 2015-2022 (USD Million)
Table 41 Europe: Market for Equipment, By Country, 2015-2022 (USD Million)
Table 42 Asia Pacific: Oligonucleotide Synthesis Market for Equipment, By Country, 2015-2022 (USD Million)
Table 43 Market, By Application, 2015-2022 (USD Million)
Table 44 Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 45 Market for Research Applications, By Region, 2015-2022 (USD Million)
Table 46 North America: Oligonucleotide Synthesis Market for Research Applications, By Country, 2015-2022 (USD Million)
Table 47 Europe: Market for Research Applications, By Country, 2015-2022 (USD Million)
Table 48 Asia Pacific: Oligonucleotide Synthesis Market for Research Applications, By Country, 2015-2022 (USD Million)
Table 49 Market for PCR Applications, By Region, 2015-2022 ( USD Million)
Table 50 North America: Market for PCR Applications, By Country, 2015-2022 (USD Million)
Table 51 Europe: Oligonucleotide Synthesis Market for PCR Applications, By Country, 2015-2022 (USD Million)
Table 52 Asia Pacific: Market for PCR Applications, By Country, 2015-2022 (USD Million)
Table 53 Market for QPCR Applications, By Region, 2015-2022 (USD Million)
Table 54 North America: Market for QPCR Applications, By Country, 2015-2022 (USD Million)
Table 55 Europe: Market for QPCR Applications, By Country, 2015-2022 (USD Million)
Table 56 Asia Pacific: Market for QPCR Applications, By Country, 2015-2022 (USD Million)
Table 57 Oligonucleotide Synthesis Market for Sequencing Applications, By Region, 2015-2022(USD Million)
Table 58 North America: Market for Sequencing Applications, By Country, 2015-2022 (USD Million)
Table 59 Europe: Market for Sequencing Applications, By Country, 2015-2022 (USD Million)
Table 60 Asia Pacific: Market for Sequencing Applications, By Country, 2015-2022 (USD Million)
Table 61 Oligonucleotide Synthesis Market for Gene Synthesis Applications, By Region, 2015-2022 (USD Million)
Table 62 North America: Market for Gene Synthesis Applications, By Country, 2015-2022 (USD Million)
Table 63 Europe: Market for Gene Synthesis Applications, By Country, 2015-2022 (USD Million)
Table 64 Asia Pacific: Market for Gene Synthesis Applications, By Country, 2015-2022 (USD Million)
Table 65 Oligonucleotide Synthesis Market for Other Research Applications, By Region, 2015-2022 (USD Million)
Table 66 North America: Market for Other Research Applications, By Country, 2015-2022 (USD Million)
Table 67 Europe: Market for Other Research Applications, By Country, 2015-2022 (USD Million)
Table 68 Asia Pacific: Market for Other Research Applications, By Country, 2015-2022 (USD Million)
Table 69 Oligonucleotide Synthesis Market for Diagnostic Applications, By Region, 2015-2022 (USD Million)
Table 70 North America: Market for Diagnostic Applications, By Country, 2015-2022 (USD Million)
Table 71 Europe: Market for Diagnostic Applications, By Country, 2015-2022 (USD Million)
Table 72 Asia Pacific: Market for Diagnostic Applications, By Country, 2015-2022 (USD Million)
Table 73 Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 74 Market for Therapeutic Applications, By Region, 2015-2022 (USD Million)
Table 75 North America: Oligonucleotide Synthesis Market for Therapeutic Applications, By Country, 2015-2022 (USD Million)
Table 76 Europe: Market for Therapeutic Applications, By Country, 2015-2022 (USD Million)
Table 77 Asia Pacific: Market for Therapeutic Applications, By Country, 2015-2022 (USD Million)
Table 78 Oligonucleotide Synthesis Market for RNAi Applications, By Region, 2015-2022 (USD Million)
Table 79 North America: Market for RNAi Applications, By Country, 2015-2022 (USD Million)
Table 80 Europe: Market for RNAi Applications, By Country, 2015-2022 (USD Million)
Table 81 Asia Pacific: Market for RNAi Applications, By Country, 2015-2022 (USD Million)
Table 82 Oligonucleotide Synthesis Market for Nucleic Acid Aptamer Applications, By Region, 2015-2022 (USD Million)
Table 83 North America: Market for Nucleic Acid Aptamer Applications, By Country, 2015-2022 (USD Million)
Table 84 Europe: Market for Nucleic Acid Aptamer Applications, By Country, 2015-2022 (USD Million)
Table 85 Asia Pacific: Oligonucleotide Synthesis Market for Nucleic Acid Aptamer Applications, By Country, 2015-2022 (USD Million)
Table 86 Market for DNA/Antisense Oligo Applications, By Region, 2015-2022 (USD Million)
Table 87 North America: Market for DNA/Antisense Oligo Applications, By Country, 2015-2022 (USD Million)
Table 88 Europe: Oligonucleotide Synthesis Market for DNA/Antisense Oligo Applications, By Country, 2015-2022 (USD Million)
Table 89 Asia Pacific: Market for DNA/Antisense Oligo Applications, By Country, 2015-2022 (USD Million)
Table 90 Market for Immunotherapy Applications, By Region, 2015-2022 (USD Thousand)
Table 91 North America: Market for Immunotherapy Applications, By Country, 2014-2021 (USD Thousand)
Table 92 Europe: Market for Immunotherapy Applications, By Country, 2015-2022 (USD Thousand)
Table 93 Asia Pacific: Oligonucleotide Synthesis Market for Immunotherapy Applications, By Country, 2015-2022 (USD Thousand)
Table 94 Market, By End User,2015-2022 (USD Million)
Table 95 Market for Academic Research Institutes, By Region, 2015-2022 (USD Million)
Table 96 North America: Market for Academic Research Institutes, By Country, 2015-2022 (USD Million)
Table 97 Europe: Oligonucleotide Synthesis Market for Academic Research Institutes, By Country, 2015-2022 (USD Million)
Table 98 Asia Pacific: Market for Academic Research Institutes, By Country, 2015-2022 (USD Million)
Table 99 Market for Pharmaceutical and Biotechnology Companies, By Region, 2015-2022 (USD Million)
Table 100 North America: Oligonucleotide Synthesis Market for Pharmaceutical and Biotechnology Companies, By Country, 2015-2022 (USD Million)
Table 101 Europe: Market for Pharmaceutical and Biotechnology Companies, By Country, 2015-2022 (USD Million)
Table 102 Asia Pacific: Oligonucleotide Synthesis Market for Pharmaceutical and Biotechnology Companies, By Country, 2015-2022 (USD Million)
Table 103 Market for Diagnostic Laboratories, By Region, 2015-2022 (USD Million)
Table 104 North America: Market for Diagnostic Laboratories, By Country, 2015-2022 (USD Million)
Table 105 Europe: Market for Diagnostic Laboratories, By Country, 2015-2022 (USD Million)
Table 106 Asia Pacific: Oligonucleotide Synthesis Market for Diagnostic Laboratories, By Country, 2015-2022 (USD Million)
Table 107 Market for Other End Users, By Region, 2015-2022 (USD Million)
Table 108 North America: Market for Other End Users, By Country, 2015-2022 (USD Million)
Table 109 Europe: Market for Other End Users, By Country, 2015-2022 (USD Million)
Table 110 Asia Pacific: Market for Other End Users, By Country, 2015-2022 (USD Million)
Table 111 Oligonucleotide Synthesis Market, By Region, 2015-2022 (USD Million)
Table 112 North America: Market, By Country, 2015-2022 (USD Million)
Table 113 North America: Market, By Product, 2015-2022 (USD Million)
Table 114 North America: Market for Synthesized Oligonucleotides, By Type, 2015-2022 (USD Million)
Table 115 North America: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015-2022 (USD Million)
Table 116 North America: Market, By Application, 2015-2022 (USD Million)
Table 117 North America: Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 118 North America: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 119 North America: Market, By End User, 2015-2022 (USD Million)
Table 120 US: Market, By Product, 2015-2022 (USD Million)
Table 121 US: Market for Synthesized Oligonucleotides, By Product 2015-2022 (USD Million)
Table 122 US: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015-2022 (USD Million)
Table 123 US: Market, By Application, 2015-2022 (USD Million)
Table 124 US: Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 125 US: Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 126 US: Market, By End User, 2015-2022 (USD Million)
Table 127 Canada: Market, By Product, 2015-2022 (USD Million)
Table 128 Canada: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Product, 2015-2022 (USD Million)
Table 129 Canada: Market for Synthesized Oligonucleotides, By Type, 2015-2022 (USD Million)
Table 130 Canada: Market, By Application, 2015-2022 (USD Million)
Table 131 Canada: Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 132 Canada: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 133 Canada: Market, By End User, 2015-2022 (USD Million)
Table 134 Europe: Market, By Country, 2015-2022 (USD Million)
Table 135 Europe: Market, By Product, 2015-2022 (USD Million)
Table 136 Europe: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Product, 2015-2022 (USD Million)
Table 137 Europe: Market for Synthesized Oligonucleotides, By Type, 2015-2022 (USD Million)
Table 138 Europe: Market, By Application, 2015-2022 (USD Million)
Table 139 Europe: Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 140 Europe: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 141 Europe: Market, By End User, 2015-2022 (USD Million)
Table 142 Germany: Market, By Product, 2015-2022 (USD Million)
Table 143 Germany: Market for Synthesized Oligonucleotides, By Product, 2015-2022 (USD Million)
Table 144 Germany: Market for Synthesized Oligonucleotides, By Type, 2015-2022 (USD Million)
Table 145 Germany: Market, By Application, 2015-2022 (USD Million)
Table 146 Germany: Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 147 Germany: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 148 Germany: Market, By End User, 2015-2022 (USD Million)
Table 149 France: Market, By Product, 2015-2022 (USD Million)
Table 150 France: Market for Synthesized Oligonucleotides, By Product, 2015-2022 (USD Million)
Table 151 France: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015-2022 (USD Million)
Table 152 France: Market, By Application, 2015-2022 (USD Million)
Table 153 France: Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 154 France: Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 155 France: Market, By End User, 2015-2022 (USD Million)
Table 156 UK: Oligonucleotide Synthesis Market, By Product, 2015-2022 (USD Million)
Table 157 UK: Market for Synthesized Oligonucleotides, By Product, 2015-2022 (USD Million)
Table 158 UK: Market for Synthesized Oligonucleotides, By Type, 2015-2022 (USD Million)
Table 159 UK: Oligonucleotide Synthesis Market, By Application, 2015-2022 (USD Million)
Table 160 UK: Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 161 UK: Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 162 UK: Market, By End User, 2015-2022 (USD Million)
Table 163 RoE: Market, By Product, 2015-2022 (USD Million)
Table 164 RoE: Market for Synthesized Oligonucleotides, By Product, 2015-2022 (USD Million)
Table 165 RoE: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015-2022 (USD Million)
Table 166 RoE: Market, By Application, 2015-2022 (USD Million)
Table 167 RoE: Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 168 RoE: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 169 RoE: Market, By End User, 2015-2022 (USD Million)
Table 170 Asia Pacific: Market, By Country, 2015-2022 (USD Million)
Table 171 Asia Pacific: Market, By Product, 2015-2022 (USD Million)
Table 172 Asia Pacific: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Product, 2015-2022 (USD Million)
Table 173 Asia Pacific: Market for Synthesized Oligonucleotides, By Type,2015-2022 (USD Million)
Table 174 Asia Pacific: Market, By Application, 2015-2022 (USD Million)
Table 175 Asia Pacific: Oligonucleotide Synthesis Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 176 Asia Pacific: Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 177 Asia Pacific: Market, By End User, 2015-2022 (USD Million)
Table 178 China: Market, By Product, 2015-2022 (USD Million)
Table 179 China: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Product, 2015-2022 (USD Million)
Table 180 China: Market for Synthesized Oligonucleotides, By Type 2015-2022 (USD Million)
Table 181 China: Market, By Application, 2015-2022 (USD Million)
Table 182 China: Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 183 China: Oligonucleotide Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 184 China: Oligonucleotide Synthesis Market, By End User, 2015-2022 (USD Million)
Table 185 Japan: Market, By Product, 2015-2022 (USD Million)
Table 186 Japan: Market for Synthesized Oligonucleotides, By Product, 2015-2022 (USD Million)
Table 187 Japan: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015-2022 (USD Million)
Table 188 Japan: Market, By Application, 2015-2022 (USD Million)
Table 189 Japan: Oligonucleotide Synthesis Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 190 Japan: Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 191 Japan: Market, By End User, 2015-2022 (USD Million)
Table 192 India: Market, By Product, 2015-2022 (USD Million)
Table 193 India: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Product, 2015-2022 (USD Million)
Table 194 India: Market for Synthesized Oligonucleotides, By Type, 2015-2022 (USD Million)
Table 195 India: Oligonucleotide Synthesis Market, By Application, 2015-2022 (USD Million)
Table 196 India: Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 197 India: Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 198 India: Market, By End User, 2015-2022 (USD Million)
Table 199 RoAPAC: Oligonucleotide Synthesis Market, By Product, 2015-2022 (USD Million)
Table 200 RoAPAC: Market for Synthesized Oligonucleotides, By Product, 2015-2022 (USD Million)
Table 201 RoAPAC: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015-2022 (USD Million)
Table 202 RoAPAC: Oligonucleotide Synthesis Market, By Application, 2015-2022 (USD Million)
Table 203 RoAPAC: Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 204 RoAPAC: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 205 RoAPAC: Market, By End User, 2015-2022 (USD Million)
Table 206 Latin America: Market, By Country/Region, 2015-2022 (USD Million)
Table 207 Latin America: Market, By Product, 2015-2022 (USD Million)
Table 208 Latin America: Market for Synthesized Oligonucleotides, By Product, 2015-2022 (USD Million)
Table 209 Latin America: Oligonucleotide Synthesis Market for Synthesized Oligonucleotides, By Type, 2015-2022 (USD Million)
Table 210 Latin America: Market, By Application, 2015-2022 (USD Million)
Table 211 Latin America: Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 212 Latin America: Oligonucleotide Synthesis Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 213 Latin America: Market, By End User, 2015-2022 (USD Million)
Table 214 Brazil: Market, By Product, 2015-2022 (USD Million)
Table 215 Brazil: Market, By Application, 2015-2022 (USD Million)
Table 216 Brazil: Oligonucleotide Synthesis Market, By End User, 2015-2022 (USD Million)
Table 217 Mexico: Market, By Product, 2015-2022 (USD Million)
Table 218 Mexico: Market, By Application, 2015-2022 (USD Million)
Table 219 Mexico: Market, By End User, 2015-2022 (USD Million)
Table 220 RoLATAM: Oligonucleotide Synthesis Market, By Product, 2015-2022 (USD Million)
Table 221 RoLATAM: Market, By Application, 2015-2022 (USD Million)
Table 222 RoLATAM: Market, By End User, 2015-2022 (USD Million)
Table 223 Middle East & Africa: Oligonucleotide Synthesis Market, By Product, 2015-2022 (USD Million)
Table 224 Middle East & Africa: Oligonucleotide Synthesis for Synthesized Oligonucleotides, Byproduct, 2015-2022 (USD Million)
Table 225 Middle East & Africa: Market for Synthesized Oligonucleotides, By Type, 2015-2022 (USD Million)
Table 226 Middle East & Africa: Oligonucleotide Synthesis Market, By Application, 2015-2022 (USD Million)
Table 227 Middle East & Africa: Market for Research Applications, By Type, 2015-2022 (USD Million)
Table 228 Middle East & Africa: Market for Therapeutic Applications, By Type, 2015-2022 (USD Million)
Table 229 Middle East & Africa: Oligonucleotide Synthesis Market, By End User, 2015-2022 (USD Million)
Table 230 Exchange Rates (Used for the Conversion of Eur to USD)

List of Figures:
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation Methodology
Figure 4 Synthesized Oligonucleotides Segment to Dominate the Global Oligonucleotide Synthesis Market During the Forecast Period
Figure 5 Intermediate-Scale Synthesis Oligonucleotides Segment to Register the Highest Growth (2017-2022)
Figure 6 Custom Oligos to Dominate the Oligonucleotide Synthesis Market
Figure 7 Research Applications to Dominate the Market in 2017
Figure 8 Diagnostic Laboratories End User Segment to Register the Highest CAGR (2017-2022)
Figure 9 North America to Hold the Largest Share in 2017 and Asia Pacific to Witness the Highest Growth (2017-2022)
Figure 10 Increasing Research Activities and Growth in the Fields of Molecular Diagnostics and Ngs are Driving Market Growth
Figure 11 Primers to Form the Major Contributing Segment of the Synthesized Oligonucleotides Market (2017-2022)
Figure 12 Custom Oligos to Dominate the Synthesized Oligonucleotides Market From 2017 to 2022
Figure 13 PCR to Command the Largest Share of the European Research Applications Market in 2017
Figure 14 RNAi Segment to Register the Highest CAGR During the Forecast Period
Figure 15 Diagnostic Laboratories to Witness Highest Growth Rate During the Forecast Period
Figure 16 China to Grow at the Highest Rate During the Forecast Period
Figure 17 Oligonucleotide Synthesis Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Market: Industry Trends
Figure 19 Synthesized Oligonucleotides to Grow at the Highest CAGR During the Forecast Period
Figure 20 Asia Pacific to Grow at the Highest Rate During the Forecast Period
Figure 21 Custom Oligonucleotides to Command the Largest Share of Synthesized Oligonucleotides Market in 2016
Figure 22 Diagnostic Applications Segment Offers Lucrative Growth Opportunities During the Forecast Period
Figure 23 Oligonucleotide Synthesis Market, By End User, 2017 vs 2022
Figure 24 Asia Pacific to Register Highest CAGR in the Oligonucleotide Synthesis Market for Academic Research Institutes
Figure 25 North America: Oligonucleotide Synthesis Market Snapshot
Figure 26 Europe: Market Snapshot
Figure 27 Asia Pacific: Market Snapshot
Figure 28 Latin America: Oligonucleotide Synthesis Market Snapshot
Figure 29 Middle East & Africa: Market Snapshot
Figure 30 Key Players Adopted Organic as Well as Inorganic Growth Strategies Between 2014 and 2017
Figure 31 Market Evolution Framework
Figure 32 Global Oligonucleotide Synthesis Market Share Analysis, By Key Player, 2016
Figure 33 Merck KGaA: Company Snapshot
Figure 34 Eurofins Scientific Group: Company Snapshot
Figure 35 Thermo Fisher Scientific: Company Snapshot
Figure 36 Agilent Technologies: Company Snapshot
Figure 37 Kaneka: Company Snapshot
Figure 38 General Electric Company (GE): Company Snapshot
Figure 39 Nitto Denko Group: Company Snapshot
Figure 40 Genscript: Company Snapshot

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Agilent Technologies
  • ATDBio
  • Bioautomation
  • Bio-Synthesis
  • Eurofins Genomics
  • Eurogentec
  • MORE

The global oligonucleotide synthesis market is expected to reach USD 2.46 Billion by 2022 from USD 1.47 Billion in 2017 at a CAGR of 10.9%. The growth of this market is mainly driven by the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.

This report segments the market into product, application, end user, and region. Based on product, the market is segmented into synthesized oligonucleotides, reagents, and equipment. In 2017, synthesized oligonucleotides are estimated to account for the largest share of the total market, followed by reagents. The growth of the synthesized oligonucleotides segment is attributed to the increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics.

Based on product, the synthesized oligonucleotides market is segmented into primers, probes, large-scale synthesis oligonucleotides, intermediate-scale synthesis oligonucleotides, and linkers & adaptors. Primers are expected to account for the largest share of the synthesized oligonucleotides market in 2017. The intermediate-scale synthesis oligonucleotides segment is projected to register the highest CAGR, due to the rising demand for synthesized oligonucleotides and innovations in manufacturing techniques to produce intermediate-scale oligonucleotides.

Based on end user, the oligonucleotide synthesis market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. The diagnostic laboratories segment is expected grow at the highest CAGR during the forecast period. This growth is attributed to the rising diagnostic applications of oligonucleotides and the growing field of molecular diagnostics.

In 2017, North America is expected to dominate the market followed by Europe. Asia Pacific is expected to grow at the highest CAGR during the forecast period. This can be attributed to factors such as the growing availability of synthesized oligos, along with an increase in R&D funding and activities in the APAC region. The increasing focus of prominent players on APAC is also supporting market growth in the region. However, price erosion and a lack of regulations for therapeutic oligonucleotides could hinder the growth of this market to a certain extent.

The oligonucleotide synthesis market is highly competitive with the presence of several small and big players. Prominent players in the market include Agilent Technologies (US), ATDBio (UK), Bio-Synthesis (US), BioAutomation (US), LGC Biosearch Technologies (US), Eurofins Genomics (Germany), Eurogentec (Belgium), GeneDesign (Japan), GE Healthcare (US), GenScript (US), Integrated DNA Technologies (IDT) (US), Nitto Denko Avecia (US), Thermo Fisher Scientific (US), TriLink Biotechnologies (US), and Sigma-Aldrich Corporation (Sigma-Aldrich) (US) (part of Merck KGAA (Germany)).

Note: Product cover images may vary from those shown
5 of 4
  • Agilent Technologies
  • ATDBio
  • Bio-Synthesis
  • Bioautomation
  • Eurofins Genomics
  • Eurogentec
  • GE Healthcare
  • Genedesign (Part of Ajinomoto)
  • Genscript
  • Integrated DNA Technologies
  • LGC Biosearch Technologies
  • Merck KGaA
  • Nitto Denko Avecia
  • Thermo Fisher Scientific
  • TriLink Biotechnologies (Part of Maravai Lifesciences)
Note: Product cover images may vary from those shown
6 of 4
Note: Product cover images may vary from those shown
Adroll
adroll